Type
- ARTG (137)
- Cancellation by sponsor (131)
- Face mask and respirator test report (11)
- Cancellation or suspension (4)
- Face mask cancellation (3)
- Prescription medicine registration (3)
- Australian Public Assessment Report (AusPAR) (2)
- Designation or determination (2)
- Prescription medicine decision summary (2)
- Face mask non-compliance notice (1)
- Prescription medicine evaluation (1)
Results for
"[search-keyword]"
Sponsor content
297 result(s) found, displaying 201 to 210
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AA-Med Pty Ltd - Iontophoresis unit, <specify>.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AA-Med Pty Ltd - Acclino® flex plus Stent - Stent, vascular, intracranial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AA-Med Pty Ltd - Alarm, enuresis.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AA-Med Pty Ltd - NeuroSlider® Microcatheter - Intravascular microflow catheter.
-
Cancellation by sponsorRequested by AA-Med Pty Ltd
-
AA-Med Pty Ltd - AtriCure cryoICE cryoFORM cryoablation probe - Cardiac cryosurgical system (311095)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AA-Med Pty Ltd - AtriCure cryoICE cryoFORM cryoablation probe - Cardiac cryosurgical system. -
Cancellation by sponsorRequested by AA-Med Pty Ltd
-
Cancellation by sponsorRequested by AA-Med Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AA-Med Pty Ltd - Clinical data collection/management information application software.
-
Prescription medicine decision summaryTGA decision: Tukysa (tucatinib), in combination with trastuzumab and capecitabine, is approved to treat HER2-positive breast cancer.